Cargando…

S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain

Ca2(+)-binding human S100A1 protein is a type of S100 protein. S100A1 is a significant mediator during inflammation when Ca(2+) binds to its EF-hand motifs. Receptors for advanced glycation end products (RAGE) correspond to 5 domains: the cytoplasmic, transmembrane, C2, C1, and V domains. The V doma...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Md. Imran, Su, Yu-Kai, Zou, Jinhao, Yang, Lee-Wei, Chou, Ruey-Hwang, Yu, Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812564/
https://www.ncbi.nlm.nih.gov/pubmed/29444082
http://dx.doi.org/10.1371/journal.pone.0190545
_version_ 1783300047888187392
author Khan, Md. Imran
Su, Yu-Kai
Zou, Jinhao
Yang, Lee-Wei
Chou, Ruey-Hwang
Yu, Chin
author_facet Khan, Md. Imran
Su, Yu-Kai
Zou, Jinhao
Yang, Lee-Wei
Chou, Ruey-Hwang
Yu, Chin
author_sort Khan, Md. Imran
collection PubMed
description Ca2(+)-binding human S100A1 protein is a type of S100 protein. S100A1 is a significant mediator during inflammation when Ca(2+) binds to its EF-hand motifs. Receptors for advanced glycation end products (RAGE) correspond to 5 domains: the cytoplasmic, transmembrane, C2, C1, and V domains. The V domain of RAGE is one of the most important target proteins for S100A1. It binds to the hydrophobic surface and triggers signaling transduction cascades that induce cell growth, cell proliferation, and tumorigenesis. We used nuclear magnetic resonance (NMR) spectroscopy to characterize the interaction between S100A1 and the RAGE V domain. We found that S100B could interact with S100A1 via NMR (1)H-(15)N HSQC titrations. We used the HADDOCK program to generate the following two binary complexes based on the NMR titration results: S100A1-RAGE V domain and S100A1-S100B. After overlapping these two complex structures, we found that S100B plays a crucial role in blocking the interaction site between RAGE V domain and S100A1. A cell proliferation assay WST-1 also supported our results. This report could potentially be useful for new protein development for cancer treatment.
format Online
Article
Text
id pubmed-5812564
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-58125642018-02-28 S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain Khan, Md. Imran Su, Yu-Kai Zou, Jinhao Yang, Lee-Wei Chou, Ruey-Hwang Yu, Chin PLoS One Research Article Ca2(+)-binding human S100A1 protein is a type of S100 protein. S100A1 is a significant mediator during inflammation when Ca(2+) binds to its EF-hand motifs. Receptors for advanced glycation end products (RAGE) correspond to 5 domains: the cytoplasmic, transmembrane, C2, C1, and V domains. The V domain of RAGE is one of the most important target proteins for S100A1. It binds to the hydrophobic surface and triggers signaling transduction cascades that induce cell growth, cell proliferation, and tumorigenesis. We used nuclear magnetic resonance (NMR) spectroscopy to characterize the interaction between S100A1 and the RAGE V domain. We found that S100B could interact with S100A1 via NMR (1)H-(15)N HSQC titrations. We used the HADDOCK program to generate the following two binary complexes based on the NMR titration results: S100A1-RAGE V domain and S100A1-S100B. After overlapping these two complex structures, we found that S100B plays a crucial role in blocking the interaction site between RAGE V domain and S100A1. A cell proliferation assay WST-1 also supported our results. This report could potentially be useful for new protein development for cancer treatment. Public Library of Science 2018-02-14 /pmc/articles/PMC5812564/ /pubmed/29444082 http://dx.doi.org/10.1371/journal.pone.0190545 Text en © 2018 Khan et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Khan, Md. Imran
Su, Yu-Kai
Zou, Jinhao
Yang, Lee-Wei
Chou, Ruey-Hwang
Yu, Chin
S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain
title S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain
title_full S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain
title_fullStr S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain
title_full_unstemmed S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain
title_short S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain
title_sort s100b as an antagonist to block the interaction between s100a1 and the rage v domain
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812564/
https://www.ncbi.nlm.nih.gov/pubmed/29444082
http://dx.doi.org/10.1371/journal.pone.0190545
work_keys_str_mv AT khanmdimran s100basanantagonisttoblocktheinteractionbetweens100a1andtheragevdomain
AT suyukai s100basanantagonisttoblocktheinteractionbetweens100a1andtheragevdomain
AT zoujinhao s100basanantagonisttoblocktheinteractionbetweens100a1andtheragevdomain
AT yangleewei s100basanantagonisttoblocktheinteractionbetweens100a1andtheragevdomain
AT chourueyhwang s100basanantagonisttoblocktheinteractionbetweens100a1andtheragevdomain
AT yuchin s100basanantagonisttoblocktheinteractionbetweens100a1andtheragevdomain